# Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma

> **NCT04671446** · — · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 120 (actual)

## Conditions studied

- Churg-Strauss Syndrome
- Eosinophilic Asthma
- Eosinophilic Esophagitis
- Eosinophilic Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** Autoantibody ELISA
- **DIAGNOSTIC_TEST:** Granulocyte Immunofluorescence

## Key facts

- **NCT ID:** NCT04671446
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2022-10-12
- **Final completion:** 2024-05-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04671446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04671446, "Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04671446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*